Home Newsfeeds Baird Initiates Coverage On Frequency Therapeutics with Outperform Rating, Announces Price Target of $10

Baird Initiates Coverage On Frequency Therapeutics with Outperform Rating, Announces Price Target of $10

Baird analyst Jack Allen initiates coverage on Frequency Therapeutics (NASDAQ:FREQ) with a Outperform rating and announces Price Target of $10.

byBenzinga Newsdesk

November 2, 2022

1 minute read

Baird analyst Jack Allen initiates coverage on Frequency Therapeutics (NASDAQ:FREQ) with a Outperform rating and announces Price Target of $10.

News
Rumors

‘Netflix Will Be Next On Microsoft’s Shopping List’ – Reuters News

By Benzinga Newsdesk

December 20, 1:27 PM

https://www.reuters.com/breakingviews/netflix-will-be-next-microsofts-shopping-list-2022-12-20/#:~:text=NEW%20YORK%2C%20Dec%2020%20(Reuters,to%20the%20list%20in%202023. Satya Nadella keeps thinking bigger.

MSFT

Apple Cuts Back On Retail Employee Raises As Pandemic-Era Generosity Fades

By Ananya Gairola

September 21, 11:45 PM

Apple has reportedly reduced pay raises for its retail employees to around 4%, a significant decrease from the approximately 8% to 10% raises given during the COVID-19 pandemic, as the company returns to pre-pandemic compensation levels.

AAPL